In tumor immunity, when cancer cells endogenously or extracellularly express GSDME, activated caspase 3 induced by various chemotherapy drugs can further cleave and activate GSDME, triggering ‘secondary apoptosis’ [10]. This evidence concerns the gene GSDME and neoplasm.